Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
Authors
Keywords
Dyslipidemia, Cardiovascular prevention, Statin, Lipoprotein, Myalgia, Treatment, Lipids, Enzymes, Creatine kinase, Lipid-lowering drug therapy
Journal
Current Cardiology Reports
Volume 15, Issue 9, Pages -
Publisher
Springer Nature
Online
2013-07-26
DOI
10.1007/s11886-013-0397-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
- (2013) et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Reply
- (2013) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
- (2012) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
- FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
- (2012) Zachary A. Marcum et al. American Journal Geriatric Pharmacotherapy
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker
- (2012) Oana Vittos et al. BIOMARKERS
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
- (2012) Samia Mora et al. CIRCULATION
- Statins and Risk of New-Onset Diabetes Mellitus
- (2012) Ravi V. Shah et al. CIRCULATION
- Low-density lipoprotein-lowering strategies
- (2012) Allan D. Sniderman et al. CURRENT OPINION IN CARDIOLOGY
- Nonalcoholic fatty liver disease and lipids
- (2012) Anthony S. Wierzbicki et al. CURRENT OPINION IN LIPIDOLOGY
- Phospholipase A2 enzymes in metabolic and cardiovascular diseases
- (2012) David Y. Hui CURRENT OPINION IN LIPIDOLOGY
- Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies
- (2012) William Nseir et al. DIGESTIVE DISEASES AND SCIENCES
- Lipid-Related Markers and Cardiovascular Disease Prediction
- (2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage)
- (2012) Ki Hoon Han et al. Journal of Clinical Lipidology
- Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists’ Collaboration meta-analysis for low-density lipoprotein lowering
- (2012) Allan Sniderman et al. Journal of Clinical Lipidology
- On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy
- (2012) Samia Mora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins for people at low risk of cardiovascular disease – Authors' reply
- (2012) Borislava Mihaylova et al. LANCET
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Statins: Is It Really Time to Reassess Benefits and Risks?
- (2012) Allison B. Goldfine NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake
- (2012) Gianluca Tognon et al. PLoS One
- Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study
- (2012) Chiadi E Ndumele et al. European Journal of Preventive Cardiology
- Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
- (2011) Olivier S. Descamps et al. ATHEROSCLEROSIS
- ESC/EAS Guidelines for the management of dyslipidaemias
- (2011) Alberico L. Catapano et al. ATHEROSCLEROSIS
- 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations
- (2011) Jacques Genest et al. CANADIAN JOURNAL OF CARDIOLOGY
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease
- (2011) Jamal S. Rana et al. Current Atherosclerosis Reports
- Statins and the risk of new-onset diabetes
- (2011) David Preiss et al. CURRENT OPINION IN LIPIDOLOGY
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Statin-induced myopathy: a review and update
- (2011) Thura T Abd et al. Expert Opinion On Drug Safety
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
- (2011) Amy Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Initiating statins in the elderly: the evolving challenge
- (2011) D Benson Walker et al. Current Opinion in Endocrinology Diabetes and Obesity
- Treating statin-intolerant patients
- (2011) Marcello Arca et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- A 50-Week Extension Study on the Safety and Efficacy of Colesevelam in Adults with Primary Hypercholesterolemia
- (2010) Michael H. Davidson et al. American Journal of Cardiovascular Drugs
- Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein
- (2010) Stefano Romeo et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
- (2010) S. Holewijn et al. JOURNAL OF INTERNAL MEDICINE
- Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains
- (2010) L. Björck et al. JOURNAL OF INTERNAL MEDICINE
- Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
- (2010) Klas Gränsbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Severe hypertriglyceridemia and pancreatitis: presentation and management
- (2009) Nils Ewald et al. CURRENT OPINION IN LIPIDOLOGY
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
- (2009) Lena Björck et al. EUROPEAN HEART JOURNAL
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A systematic review and meta-analysis on the therapeutic equivalence of statins
- (2009) T.-C. Weng et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
- (2008) Christopher P. Cannon et al. AMERICAN HEART JOURNAL
- Comparison of Benefits and Risks of Rosuvastatin Versus Atorvastatin from a Meta-Analysis of Head-to-Head Randomized Controlled Trials
- (2008) John Wlodarczyk et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lowering LDL Cholesterol in Adults: A Prospective, Community-Based Practice Initiative
- (2008) Gregg O. Coodley et al. AMERICAN JOURNAL OF MEDICINE
- Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia
- (2008) M. Florentin et al. CURRENT MEDICAL RESEARCH AND OPINION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now